The FDA has approved Gilead Science’s antiviral IV drug remdesivir — also known as Veklury — for adults and children aged older than 12 years when treatment of COVID-19 requires hospitalization.
The drug is the first approved therapy for COVID-19.
The approval of remdesivir does not extend to the entire population that had been authorized to use it under an emergency use authorization that was issued May 1, the agency said.
According to a press release, the approval of remdesivir was based on three randomized controlled trials. In the first (Read more...)
Uncategorized